Roche, Allergan Sue Apotex Again Over Acular Patent

Law360, New York (June 6, 2005, 12:00 AM EDT) -- Swiss drug maker Roche and licensee Allergan Inc. have sued Canadian generics maker Apotex in a California federal court over its plans to make a generic version of the eye-inflammation treatment Acular.

The complaint, filed by Roche Palo Alto LLC and Allergan, was filed shortly after the U.S. Court of Appeals for the Federal Circuit granted Apotex a second chance to seek the invalidation of a patent for Acular.

Apotex filed an abbreviated new drug application with the U.,S. Food and Drug Administration for Acular with...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.